Amy Beasley

Amy Beasley is a seasoned clinical operations professional with extensive experience in the pharmaceutical industry. Currently serving as a Global Study Manager at Pfizer since December 2023, Amy previously held the position of Senior Clinical Trial Manager at Seagen, leading a phase III oncology study in metastatic breast cancer. Prior to this, Amy managed clinical operations at Savara Inc. for phase IIa and phase III studies in NTM and Cystic Fibrosis, and worked as a Clinical Project Leader at Sanofi, focusing on diabetes studies and digital recruitment initiatives. Amy's career began at Amgen, where a progressive role in clinical trial operations was established, culminating as Sr. Manager of Clinical Site Management Oversight. Academic qualifications include a BS in Medical Technology from The University of Texas Medical Branch and an MPH in Epidemiology from Emory University.